Here’s what you should know:
1. Cigna made a $54 billion bid for Express Scripts in March. Sources familiar with the investor told the Wall Street Journal Mr. Icahn plans to vote against the acquisition, CNBC reports..
2. Cigna is paying Express Scripts shareholders $96.03 per share, which he feels is too high.
3. Express Scripts is currently trading at $79.20 per share.
4. Mr. Icahn holds about 5 percent of Cigna. He is attempting to convince other shareholders to vote against the deal with him.
5. Analysts are already fearful the deal could be met with regulatory scrutiny, which could be suppressing current share price. To that point, California’s Insurance Commissioner urged the U.S. Department of Justice to block the deal.
More articles on supply chain:
Staying in step with contractual and coding changes
Why flexibility is a key quality for ASCs today
Pentax, Takeda & more — 6 GI company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.